Dave Lemus joins Silence Therapeutics Boar...Silence Therapeutics plc, a company active in the development of RNA therapeutics, has announced the appointment of Dave Lemus to its Board as Non-Executive Director. more ➔
Abivax Appoints Ian McGowanAbivax, a biotechnology company working to develop a functional cure for HIV as well as treatments for inflammatory/autoimmune diseases and cancer, appoints Ian McGowan as Scientific Advisory Board Chair … more ➔
New DirectorT cell therapy developer Crescendo Biologics Ltd (Crescendo) has named Eva-Lotta Allan Non-Executive Director of the company. The former CFO of Immunocore brings in over 30 years experience in the … more ➔
Dirk Kersten joins Forbion as General Part...Forbion, a European life science venture capital firm, today announces that Dirk Kersten will join as a General Partner on October 1st, 2018. more ➔
Cell Medica Appoints Julia P. GregoryCell Medica, today announced the appointment of Julia P. Gregory as a Non-Executive Director and Audit Chair of the Companys Board of Directors. more ➔
Tigenix announces change in Board of Direc... Tigenix NV, a biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic stem cells, today announces that Eduardo Bravo will depart the board of directors and his … more ➔
Josh Muntner joins Mesoblast as CFOJosh Muntner has been appointed Chief Financial Officer of Mesoblast. He will be based in New York. more ➔
PureTechs Gelesis Appoints Harry Leider...PureTech Health plc announced today that its affiliate, Gelesis, has appointed Harry Leider, MD, MBA, former Chief Medical Officer and Group Vice President of Walgreens, as Chief Medical Officer. more ➔
Hikma appoints Henriette NielsenHikma Pharmaceuticals PLC announces the appointment of Henriette Nielsen to the newly created role of Chief Transformation Officer. more ➔
Sygnature Discovery appoints Dr Bill Marat...Sygnature Discovery, thas appointed Dr Bill Marathias as Vice President of Business Development for the US to assist with the companys international growth plans. more ➔
